Thermo Fisher Scientific (NYSE:TMO) PT Lowered to $718.00
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) had its price objective decreased by equities researchers at Royal Bank of Canada from $767.00 to $718.00 in a research note issued on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the medical research company’s stock. Royal Bank of Canada’s target price would indicate […]
26 Oct 11:13 · The Markets Daily